19 June 2013
Keywords: noscal, launch, japan, delayed, sankyo, postpone, introduction
Article | 08 April 1996
Sankyo will postpone the introduction of Noscal (troglitazone), a novel treatment for diabetes, until new trials to confirm the safety ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.